$11.28 -0.11 (-0.97%)
11/6/2009 4:00 PM

BioCryst Pharmaceuticals, Inc. (BCRX)

CAPS Rating: 1 out of 5

A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections.

Current Price $11.28 Mkt Cap $433.95M
Open $10.94 P/E Ratio 0.00
Prev. Close $11.39 Div. (Yield) N/A (N/A)
Daily Range $10.68 - $11.35 Volume 2,798,990
52-Wk Range $0.85 - $13.47 Avg. Daily Vol. 2,557,000

BCRX News and Commentary

Caps

How do you think BCRX will perform vs the S&P 500?

Add Stock to Watchlist

All Members

174 Outperform
85 Underperform
 

All-Star Members

37 Outperform
45 Underperform
 

Wall Street

1 Outperform
1 Underperform
 

Top BCRX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

DogDayAftern00n (75.69)
Submitted June 06, 2009

Speculative play based on bullish sentiment from Michael Murphy; big potential if Emergency Use Authorization is granted in the next few weeks.

zzlangerhans (99.36)
Submitted April 29, 2009

BioCryst has enjoyed a near triple on the back of their developmental drug peramivir, thanks to the pequeno viru that could from our neighbors to the South. But a cursory review of peramivir's history tells us that it is no compound to build an… More

BCRX VS S&P 500 (SPY)

Fools bullish on BCRX are also bullish on:

Recent Community Commentary

Read the most recent pitches from members about BCRX.

Recs

0
Member Avatar Ki11tank (< 20) Submitted: 11/5/2009 2:02:29 PM : Outperform Start Price: $11.53 BCRX Score: -2.87

peramivir.. govt approval.. govt sales.. worldwide interest.. practically just starting off this move..

$2250 per course.

Recs

0
Member Avatar billmilosh (< 20) Submitted: 11/2/2009 10:49:24 PM : Outperform Start Price: $9.94 BCRX Score: +10.21

If flue turns really bad, these guys have an IV solution. Working hard for international sales.

Recs

0
Member Avatar cashsage (60.05) Submitted: 10/27/2009 5:55:49 AM : Underperform Start Price: $10.94 BCRX Score: -3.01

BCRX has a too high valuation compared to its sales potential. It is also one of the most loss making companies at least until 2011.

Leaderboard

Find the members with the highest scoring picks in BCRX.

Score Leader

omichel

omichel (< 20) Score: +308.53

The Score Leader is the member with the highest score across all their picks in BCRX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score Commentary
omichel < 20 6/20/2008 Outperform 3M $2.88 +291.67% -16.87% +308.53
sherzee 40.21 6/13/2008 Outperform NS $2.90 +288.95% -17.53% +306.48
bsrobins 73.72 8/12/2008 Outperform 5Y $3.08 +266.23% -14.94% +281.18
japee5 < 20 8/15/2008 Outperform 3M $3.12 +261.54% -14.93% +276.47
glittergates < 20 3/18/2008 Outperform 1Y $3.21 +251.40% -14.52% +265.92
mdriver78 < 20 8/5/2008 Outperform 3Y $3.22 +250.31% -12.30% +262.61 1 Comment
millerto 30.13 7/29/2008 8/28/2008 Outperform 3M $3.24 +248.15% -11.31% +259.45
NETREDNU 98.75 5/11/2009 Outperform NS $3.00 +276.00% +18.04% +257.96
WileyChannell < 20 8/4/2008 Outperform 5Y $3.28 +243.90% -12.33% +256.23 1 Comment
SCTim10 79.69 3/25/2008 Outperform NS $3.75 +200.80% -17.62% +218.42

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJMP < 20 10/14/2009 Outperform NS $8.67 +30.10% -0.24% +30.35
TrackCarisandCo 78.62 8/10/2007 Outperform NS $9.40 -21.49% +5.86% -27.35 9/20/2007 @ $7.38
TrackJimCramer < 20 5/4/2006 Underperform 3W $14.62 -22.85% -12.78% +10.06

Featured Broker Partners